January 2024 FDA Recall Fosfomycin Tromethamine by Ascend Laboratories, Llc
D-0339-2024 - Failed Impurities/Degradation Specification

This Class II drug recall was voluntarily initiated by Ascend Laboratories, Llc on January 16, 2024 for the product Fosfomycin Tromethamine. The FDA reported the reason for recall as failed impurities/degradation specification. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0339-2024

Reason for Recall
Failed Impurities/Degradation Specification: Out of specification for organic impurities
Initiated
01-16-2024
Reported
02-28-2024
Quantity
71,244 sachets

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Ascend Laboratories, LLC
Nationwide in the USA
Fosfomycin Tromethamine Granules for Oral Solution, (equivalent to 3 grams of fosfomycin), single-dose sachet, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA. Distributed by: Ascend Laboratories, LLC. Parsippany, NJ 07054. NDC 67877-749-57

Batch or Lot Expiration Information

Lot# lOTS #: 22121458, 22121459, 22121460, 22121461, 22121462, 22121463, 22121464, Exp 4/2024; 22121176, 22121407, 22121465, Exp 3/2024; 22121761, 22121762, 22121763, 22121764, 22121766, 22121968, 22121969, Exp 5/2024.

Affected Packages Involved in this Recall